Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
4.38
0.18 (4.29%)
At close: Sep 25, 2025, 3:59 PM
4.43
1.14%
After-hours: Sep 25, 2025, 05:00 PM EDT
4.29% (1D)
| Bid | 4.31 |
| Market Cap | 298.08M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -122.47M |
| EPS (ttm) | -2.36 |
| PE Ratio (ttm) | -1.86 |
| Forward PE | -61.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.43 |
| Volume | 1,175,371 |
| Avg. Volume (20D) | 1,135,125 |
| Open | 4.20 |
| Previous Close | 4.20 |
| Day's Range | 4.13 - 4.41 |
| 52-Week Range | 2.95 - 13.60 |
| Beta | 2.37 |
| Ex-Dividend Date | n/a |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsOmeros Corporation is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
9 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
2 months ago · businesswire.com
Omeros Corporation Announces Pricing of $22 Million Registered Direct OfferingSEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) announced that on July 24, 2025 it entered into a securities purchase agreement with Polar Asset Management Part...
